Loading…
Loading grant details…
| Funder | Wellcome Trust |
|---|---|
| Recipient Organization | World Health Organization, Switzerland |
| Country | United States |
| Start Date | Apr 01, 2021 |
| End Date | Sep 28, 2022 |
| Duration | 545 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | 222215 |
Sub-Saharan Africa has a high snakebite burden, compounded by a lack of safe, effective and affordable treatments that are accessible to victims.
Across seven East African countries (Ethiopia, South Sudan, Uganda, Kenya, Tanzania, Rwanda and Burundi) there are an estimated 89,940 (95% Confidence Interval: 74,511-105,385) cases of snakebite each year, while in seven West African nations (Cameroon, Nigeria, Chad, Togo, Benin, Ghana and Burkina Faso) there are 70,712 (95% CI: 58,348-84,791) cases annually.
Access to snake antivenoms for the treatment of snakebite envenoming in sub-Saharan Africa has been declining since at least the 1970’s and current data provided to WHO suggests that
World Health Organization, Switzerland
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant